We are live on ! Find out more
AllianceBernstein

AllianceBernstein Portfolio holdings

AUM $309B
1-Year Est. Return 23.92%
 

AllianceBernstein (AB), formed in 2000 through the merger of Alliance Capital and Bernstein, is a global asset management firm headquartered in Nashville, Tennessee, managing over $759 billion in assets as of late 2024 for institutional investors, financial advisors, and individuals. Known for its research-driven approach, AB offers a diverse range of investment strategies, including equities, fixed income, alternatives, and multi-asset solutions, with a strong emphasis on active management and ESG (environmental, social, governance) integration. The firm, which relocated its headquarters from New York City to Nashville in 2021, operates globally with significant operations in New York, London, and Asia, leveraging its Bernstein Research arm for deep market insights. With a workforce of over 4,700 and a partnership structure led by CEO Seth Bernstein, AB combines a legacy of rigorous analysis with a modern focus on sustainable investing and client outcomes.

This Fund
S&P 500
This Quarter Est. Return
+4.56%
1 Year Est. Return
+23.92%
3 Year Est. Return
+92.38%
5 Year Est. Return
+118.97%
10 Year Est. Return
+515.32%
AUM
$295B
AUM Growth
-$3.08B
Cap. Flow
-$7.58B
Cap. Flow %
-2.57%
Top 10 Hldgs %
30.42%
Holding
3,298
New
67
Increased
918
Reduced
1,605
Closed
77

Top Sells

Rank Stock Value
1
VRTX icon
Vertex Pharmaceuticals
VRTX
+$1.6B
2
DIS icon
Walt Disney
DIS
+$795M
3
IDXX icon
Idexx Laboratories
IDXX
+$692M
4
ZTS icon
Zoetis
ZTS
+$640M
5
MSFT icon
Microsoft
MSFT
+$615M

Sector Composition

Rank Sector Weight
1 Technology 29.02%
2 Healthcare 12.31%
3 Consumer Discretionary 11.7%
4 Financials 11.01%
5 Communication Services 9.9%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
OPFI icon
3051
OppFi
OPFI
$804M
$172K ﹤0.01%
22,390
CRON
3052
Cronos Group
CRON
$1.07B
$171K ﹤0.01%
84,598
EDIT icon
3053
Editas Medicine
EDIT
$411M
$170K ﹤0.01%
133,630
-1,200
-0.9% -$3.06K
MKZR
3054
MacKenzie Realty Capital
MKZR
$2.82M
$169K ﹤0.01%
+5,358
New +$204K
NRDY icon
3055
Nerdy
NRDY
$109M
$167K ﹤0.01%
102,950
LSEA
3056
DELISTED
Landsea Homes
LSEA
$164K ﹤0.01%
19,370
CDZI icon
3057
Cadiz
CDZI
$259M
$164K ﹤0.01%
31,590
-5,160
-14% -$18.6K
LE icon
3058
Lands' End
LE
$375M
$164K ﹤0.01%
12,500
-149,410
-92% -$2.34M
AMPX icon
3059
Amprius Technologies
AMPX
$1.38B
$164K ﹤0.01%
58,460
TPIC
3060
DELISTED
TPI Composites
TPIC
$163K ﹤0.01%
86,290
NREF
3061
NexPoint Real Estate Finance
NREF
$318M
$163K ﹤0.01%
10,390
ERO icon
3062
Ero Copper
ERO
$2.73B
$163K ﹤0.01%
12,080
INDV icon
3063
Indivior Pharmaceuticals
INDV
$4.73B
$162K ﹤0.01%
13,034
SRI icon
3064
Stoneridge
SRI
$210M
$160K ﹤0.01%
25,470
-13,193
-34% -$101K
SEDG icon
3065
SolarEdge
SEDG
$2.62B
$160K ﹤0.01%
11,740
-10,673
-48% -$164K
CATX icon
3066
Perspective Therapeutics
CATX
$322M
$159K ﹤0.01%
49,690
TE
3067
T1 Energy
TE
$1.37B
$158K ﹤0.01%
61,380
ALEC icon
3068
Alector
ALEC
$168M
$155K ﹤0.01%
82,100
-629,445
-88% -$2.37M
GRWG icon
3069
GrowGeneration
GRWG
$88.9M
$155K ﹤0.01%
91,770
NATR icon
3070
Nature's Sunshine
NATR
$362M
$155K ﹤0.01%
10,570
RMNI icon
3071
Rimini Street
RMNI
$432M
$155K ﹤0.01%
57,990
NRGV icon
3072
Energy Vault
NRGV
$531M
$154K ﹤0.01%
67,640
CLAR icon
3073
Clarus
CLAR
$126M
$153K ﹤0.01%
33,824
AKBA icon
3074
Akebia Therapeutics
AKBA
$343M
$148K ﹤0.01%
77,640
AQST icon
3075
Aquestive Therapeutics
AQST
$468M
$147K ﹤0.01%
41,290

Similar funds

AllianceBernstein's Q4 2024 Portfolio in Review

As of Q4 2024, AllianceBernstein held 3,298 positions worth $295B, down 1% from $298B the previous quarter. Its ten largest holdings account for 30% of the portfolio.

Trading was light in Q4 2024: portfolio turnover was 4.4%. AllianceBernstein opened 67 new positions and exited 77, leaving the 3,298-position portfolio largely intact.

By sector, the portfolio is most concentrated in Technology at 29% of assets, up from 28% a quarter earlier, followed by Healthcare and Consumer Discretionary.

  • AllianceBernstein's largest Q4 2024 buy was iShares iBoxx $ High Yield Corporate Bond ETF: 2,000,000 shares worth $157M.
  • AllianceBernstein added most to Cboe Global Markets in Q4 2024, an estimated $1.07B increase.
  • AllianceBernstein's biggest Q4 2024 reduction was Vertex Pharmaceuticals, cutting an estimated $1.6B.
  • AllianceBernstein fully exited iShares US Treasury Bond ETF in Q4 2024, selling an estimated $176M.
  • AllianceBernstein's ten largest holdings make up 30% of its $295B portfolio in Q4 2024.
  • AllianceBernstein opened 67 new positions and closed 77 in Q4 2024.
  • AllianceBernstein's portfolio value fell 1% quarter-over-quarter to $295B.

Based on AllianceBernstein's 13F filing for Q4 2024, filed 12 Feb 2025.